Today: 27 June 2026
Coinbase stock rises as Bitcoin ticks higher — but a DEX balance glitch puts nerves back in play
20 February 2026
2 mins read

Coinbase stock rises as Bitcoin ticks higher — but a DEX balance glitch puts nerves back in play

New York, Feb 20, 2026, 15:38 ET — Regular session

  • Coinbase gained 2.7% in afternoon action, while bitcoin hovered roughly 1% higher.
  • Coinbase reported it’s looking into a display glitch that’s impacting DEX token balances. The company said user funds remain safe.
  • A broker trimmed its price target on Coinbase but stuck with a sell rating. Investors remain focused on trading volumes.

Coinbase Global climbed Friday, gaining $4.56 to $170.50, or 2.7%, boosted by a stronger bitcoin. The crypto exchange did, however, note a glitch affecting balances for decentralized-exchange tokens.

Timing’s a factor here. As Coinbase pushes to diversify beyond plain spot crypto trading, volatility is fading and trading volumes are drying up—meaning there’s little tolerance now for even minor operational slip-ups.

The company is pushing further into “onchain” activity — trades and transfers executed straight on blockchains — and here, customers don’t hesitate to pull funds at the first whiff of friction. Trust and uptime are back in focus as investment factors, not just the price action in crypto.

Coinbase flagged a problem with DEX token balances, telling users, “This is purely a display issue, and your funds are safe,” as it worked on a fix. The exchange’s status page also listed a Solana send-and-receive delay from earlier this day, later marked as resolved, plus a DEX trading performance snag dated Feb. 18, which Coinbase said wrapped up early Feb. 19. status.coinbase.com

Risk appetite pulled crypto stocks higher Friday, following the U.S. Supreme Court’s decision to overturn President Donald Trump’s global tariffs. Equities caught a boost, despite December’s inflation data coming in hotter than expected.

Some skepticism lingers around Coinbase’s rally. Compass Point Research & Trading is sticking with its sell call, dropping its price target to $140 from $190, MarketScreener noted in its broker move summary.

Coinbase is still working through the aftermath of a tough quarter. The company unexpectedly reported a loss last week, after sluggish trading volumes dented transaction revenues, according to Reuters. “It’s all about the company’s diversification and ‘shock absorbers’,” said David Bartosiak, stock strategist at Zacks Investment Research, who singled out the rising role of stablecoins and subscriptions. Reuters

Management isn’t letting up on that theme. “The Everything Exchange is working,” CEO Brian Armstrong told shareholders, pointing to growth outside crypto and a slate of new products. The update also called out moves into other tradable assets. Business Wire

Coinbase, in its latest quarterly shareholder letter, reported it had pulled in roughly $420 million in transaction revenue through Feb. 10 for the first quarter. The company expects Q1 subscription and services revenue to land somewhere between $550 million and $630 million.

Peers showed no clear direction. Robinhood Markets ticked up 0.6%, and bitcoin-holder Strategy picked up close to 1%. But shares of miners Riot Platforms and Marathon Digital slipped.

The worry for Coinbase? If the display problem sticks around or starts to mess with performance, regular users could start drifting to competitors. And with fee revenue on the line, the company can’t afford that. If crypto trading stays slow, that’s another blow — lower volatility means fewer trades, and the pressure keeps building.

Traders are watching to see if the DEX-related issue remains isolated, while also waiting for new macro cues that could move risk assets. Coming up: January’s U.S. producer price index lands Feb. 27, and the Fed convenes for its next policy meeting March 17-18.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Sangoma Technologies Stock Fair Value Cut as Analysts Adjust Assumptions
    June 27, 2026, 10:56 AM EDT. Sangoma Technologies (TSX:STC) saw its fair value estimate cut from CA$11.36 to CA$9.92 as analysts revised key assumptions including revenue growth and profit margins. The revenue growth outlook shifted from a 4.33% decline to a 2.24% increase, while net profit margin assumptions were significantly adjusted. The price-to-earnings (P/E) ratio forecast moved higher from 14.51x to 18.10x, and the discount rate for cash flows rose from 7.71% to 8.52%, reflecting increased risk. Analysts remain cautiously optimistic about the company's execution potential but highlight valuation uncertainties. This update underscores the evolving narrative around Sangoma's financial prospects and invites investors to reassess risks and opportunities in the stock.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines
Previous Story

GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop